WILMINGTON, Delaware, May 16 -- AstraZeneca, a biopharmaceutical company, issued the following news release: * * * ENHERTU(R) (fam-trastuzumab deruxtecan-nxki) approved in the US for two new indications for patients with HER2-positive early breast cancer Approved for use before surgery based on DESTINY-Breast11 Phase III trial Approved for use following surgery based on DESTINY-Breast05 Phase III trial Two new indications bring AstraZeneca and Daiichi Sankyo's Enhertu into curative -intent setting, reinforcing its role across stages of H more PR

ORLANDO, Florida, May 14 -- The University of Central Florida posted the following news: * * * Natural Chemical Factories: UCF Study Reveals How Bacteria Build Explosive-Like Molecules * Scientists at UCF have discovered how certain bacteria can produce molecules chemically similar to those used in explosives, revealing a previously unknown pathway for building complex, nitrogen-rich compounds. The study, led by UCF associate professor of chemistry Jonathan Caranto, identifies hydrazinoacetic acid as a key building block in the production more PR

SOUTH ORANGE, New Jersey, May 15 -- Seton Hall University posted the following news: * * * Seton Hall University Celebrates 170th Commencement * Seton Hall University will be celebrating its 170th Baccalaureate Commencement ceremony at 8:30 a.m. on Monday, May 18, 2026, at the Prudential Center, 165 Mulberry Street in Newark, New Jersey. Delivering the commencement keynote address will be Arthur C. Brooks, Ph.D., professor at the Harvard Kennedy School and the Harvard Business School and best-selling author. The Baccalaureate Ceremony will  more PR